Related Experiment Video
Updated: Jun 16, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Immunity to stemness genes in human cancer
1Section of Hematology, Yale University, New Haven, CT 06510, USA. madhav.dhodapkar@yale.edu
Human tumors exhibit cellular plasticity and stemness pathways overlapping with embryonal stem (ES) cells. Targeting these cancer stem cell (CSC) pathways offers new avenues for immune-based cancer therapies and regenerative medicine.
Area of Science:
- Oncology
- Immunology
- Stem Cell Biology
Background:
- Human tumors display intraclonal heterogeneity and plasticity in cellular differentiation.
- There is a notable overlap between pathways regulating pluripotency in embryonal stem (ES) cells and those involved in oncogenesis.
- Cancer stem cells (CSCs) share characteristics with ES cells, suggesting common regulatory mechanisms.
Purpose of the Study:
- To explore the immunologic targeting of stemness pathways in cancer.
- To discuss the implications of targeting these pathways for cancer therapy and regenerative medicine.
- To review recent insights into the immune system's capacity to target cancer stem cell pathways.
Main Methods:
- Review of recent scientific literature on cancer stem cells, pluripotency pathways, and immunologic targeting.
- Analysis of the overlap between ES cell pluripotency pathways and oncogenesis.
- Discussion of the immune system's role in targeting stemness-associated antigens.
Main Results:
- Stemness pathways in ES cells and cancer stem cells (CSCs) present novel therapeutic targets.
- The immune system has the capacity to recognize and target pathways associated with stemness.
- Targeting these pathways holds potential for both cancer treatment and regenerative therapies.
Conclusions:
- The plasticity and stemness of cancer cells, particularly cancer stem cells (CSCs), offer new targets for immunotherapy.
- Leveraging the immune system to target stemness pathways could lead to more effective cancer treatments.
- Understanding these pathways is crucial for advancing both cancer immunology and regenerative medicine using embryonal stem cells.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

